Wednesday
June 4
Tuesday
June 3
Sunday
June 1
Monday
June2
Saturday
May31
0768
8:30am - 8:45am
WHENACCOUNTINGFORWAKEFULNESS,
COMPLETEDSUICIDESEXHIBITAN INCREASED
LIKELIHOODDURINGCIRCADIANNIGHT
PerlisML, GrandnerMA, BasnerM, Chakravorty
S, BrownGK, MoralesKH, ThaseME, DingesDF,
GehrmanPR, ChaudharyNS
0769
8:45am - 9:00am
SLEEPQUALITY INPREGNANCYPREDICTS
POSTPARTUMDEPRESSIONANDSTRESS
StoneKC, Miller-Loncar CL, SalisburyAL
0770
9:00am - 9:15am
YOU’LLFEELBETTER INTHEMORNING:
SLOWWAVEACTIVITYANDOVERNIGHT
MOODREGULATION INBIPOLARDISORDER
SoehnerAM,SaletinJ,KaplanKA,Talbot LS,Hairston
I,EidelmanP,Gruber J,WalkerM,HarveyAG
0771
9:15am - 9:30am
ASEVEN-DAYACTIGRAPHYBASEDSTUDY
OFSLEEPDISTURBANCE INHIGHTRAIT
RUMINATORS
Pillai V, KalmbachD, RothT, DrakeCL
0772
9:30am - 9:45am
NEUROBIOLOGICALEFFECTSOFPRAZOSIN
ONNREMSLEEP INVETERANSWITHPTSD
Suter D, MammenO, InsanaS, Nofzinger E,
GermainA
0773
9:45am - 10:00am
THERELATIONSHIPBETWEENCORTISOL
OUTPUTANDSLEEPEEG INAUTISTICAND
TYPICALLYDEVELOPEDADULTS
ChicoineM, LimogesÉ, Chevrier É, LupienS,
Mottron L, Godbout R
S09: UpperAirwayStimulation for
ObstructiveSleepApnea
8:00am– 10:00am
Room 101E
Chair:
Atul Malhotra, MD
Faculty:
Scott Longert; AlanSchwartz,MD; Ryan
Soose,MD; KingmanStrohl,MD; andPatrickStrollo Jr.,MD
Psychologist Level of Content:
Intermediate
Objectives:
1. Review themechanism of upper airway stimulation
(UAS) therapy;
2. Describe the clinical phenotypes that benefit fromUAS;
3. Discuss the surgical implantation technique;
4. Analyze the safety and efficacy of UAS; and
5. Evaluate thepatient’s experiencewithUAS.
8:00am – 8:10am
UAS:APatient’sPerspective
Scott Longert
8:10am – 8:35am
UASPrior FeasibilityStudies
andMechanismofAction
AlanSchwartz, MD
8:35am – 9:00am
Patient Selection andSurgical
Technique
RyanSoose, MD
9:00am – 9:25am
STARTrial: Safety andLong-
termEffectiveness
KingmanStrohl, MD
9:25am – 9:50am
UAS:Management andHealth
Economics
PatrickStrollo Jr., MD
9:50am – 10:00am
Summary andDiscussion
Atul Malhotra, MD
S10: Sleep Loss and Inflammation
inMiceandMan: Cytokine
Mechanisms for Sleep andHealth
Outcomes
8:00am – 10:00am
Room 205A
Co-chairs:
JamesKrueger, PhD; andMarkOpp, PhD
Faculty:
DavidGozal, MD; LeilaKheirandish-Gozal, MD;
andAlexandrosVgontzas, MD
Psychologist Level of Content:
Intermediate
Objectives:
1. Describe the relationships between sleep regulatory
molecules andmolecules regulating inflammation;
2. Identifymechanisms bywhich localized inflammation
can result in changes in sleep;
3. Recognize that sleep disruption, sleepapnea,
obesity, aging andpain areassociatedwith lowgrade
inflammation; and
69
